Purpose and Summary
Introduced on February 24, 2023, by Representative Juan
Vargas, H.R. 1166, the Public Health Emergency Medical Supplies
Enhancement Act of 2023, amends sections of the Defense
Production Act (DPA) (50 U.S.C. Sec. 4501-4568) to, among other
things, identify certain materials as scarce and critical
during a public health emergency period. The bill would also
authorize the prioritization of materials for the federal
government to exclude state, local, or tribal purchases and
creates an outreach representative position to work with the
private sector. Finally, the bill would direct the President to
issue a report on the authorities exercised and to provide
briefings four months after the submission of the report.
Background and Need for Legislation
The DPA allows the President to require companies to
prioritize and accept contracts to meet national defense
requirements. The DPA also allows for the President to
incentivize production through loans, loan guarantees, and
purchase commitments. The COVID-19 pandemic underscored the
potential for infectious disease to undermine U.S. national
security interests. Together with Operation Warp Speed, the
Trump Administration used the DPA 18 times to accelerate the
delivery of COVID-19 therapeutics and related equipment. H.R.
1166 is designed to ensure that materials essential for
national defense are covered by the DPA during a public health
emergency. The bill also provides clarity when federal
purchases may appear to conflict with certain state, local, or
tribal deliveries.
HEARING
Pursuant to clause 3(c)(6) of rule XIII, the following
hearing was used to develop H.R. 1166: The Committee on
Financial Services held a hearing on February 7, 2023, titled
``Combatting the Economic Threat from China.''
Committee Consideration
The Committee on Financial Services met in open session on
February 28, 2023, and ordered H.R. 1166 to be reported
favorably to the House as amended by a recorded vote of 30 ayes
to 2 nays (Record vote no. FC-23), a quorum being present.
Before the question was called to order the bill favorably
reported, the Committee adopted an amendment in the nature of a
substitute offered by Mr. Vargas by voice vote.
Committee Votes
Clause 3(b) of rule XIII of the Rules of the House of
Representatives requires the Committee to list the record votes
on the order to report legislation and amendments thereto. H.R.
1166 was ordered reported favorably to the House as amended by
a recorded vote of 30 ayes to 2 nays (Record vote no. FC-23), a
quorum being present.
[GRAPHIC(S) NOT AVAILABLE IN TIFF FORMAT]
COMMITTEE OVERSIGHT FINDINGS
Pursuant to clause 3(c) of rule XIII of the Rules of the
House of Representatives, the findings and recommendations of
the Committee based on oversight activities under clause
2(b)(1) of rule X of the Rules of the House of Representatives,
are incorporated in the descriptive portions of this report.
PERFORMANCE GOALS AND OBJECTIVES
Pursuant to clause 3(c)(4) of rule XIII of the Rules of the
House of Representatives, the goal of H.R. 1166 is to require
the identification of certain materials as scarce and critical
during a public health emergency period. The bill would also
authorize the prioritization of materials for the federal
government to exclude state, local, or tribal purchases and
creates an outreach representative position to work with the
private sector.
CONGRESSIONAL BUDGET OFFICE ESTIMATES
Pursuant to clause 3(c)(3) of rule XIII of the Rules of the
House of Representatives, the following is the cost estimate
provided by the Congressional Budget Office pursuant to section
402 of the Congressional Budget Act of 1974:
[GRAPHIC(S) NOT AVAILABLE IN TIFF FORMAT]
During the coronavirus pandemic the Administration--through
a series of executive orders--used authorities under the
Defense Production Act of 1950 (DPA) to require businesses to
prioritize performance and delivery on contracts and orders
from the federal government.\1\ It also used the act's
authorities to support manufacturing of medical supplies and
vaccines, fund projects to expand domestic production of
personal protective equipment (PPE), and partner with private
companies to distribute PPE.
---------------------------------------------------------------------------
\1\See, for example, ``America's Supply Chains,'' Executive Order
14017, 86 Fed. Reg. 11849 (February 24, 2021), https://tinyurl.com/
bdhmc8kc; ``A Sustainable Public Health Supply Chain,'' Executive Order
14001, 86 Fed. Reg. 7219 (January 21, 2021), https://tinyurl.com/
2pa3b7af; ``Combating Public Health Emergencies and Strengthening
National Security by Ensuring Essential Medicines, Medical
Countermeasures, and Critical Inputs Are Made in the United States,''
Executive Order 13944, 85 Fed. Reg. 49929 (August 6, 2020), https://
tinyurl.com/yupmducj; ``Delegating Additional Authority Under the
Defense Production Act With Respect to Health and Medical Resources to
Respond to the Spread of COVID-19,'' Executive Order 13911, 85 Fed.
Reg. 18403 (March 27, 2020), https://tinyurl.com/mr2p7c56; and
``Prioritizing and Allocating Health and Medical Resources to Respond
to the Spread of COVID-19,'' Executive Order 13909, 85 Fed. Reg. 16227
(March 18, 2020), https://tinyurl.com/bdehbd47.
---------------------------------------------------------------------------
H.R. 1166 would amend the DPA to specifically incorporate
some of the effects of those orders. The bill also would
authorize the Federal Emergency Management Agency (FEMA) to
appoint an outreach representative to work with industry during
public health emergencies. FEMA and the Department of Health
and Human Services established a position that fulfilled that
requirement as part of the Supply Chain Stabilization Task
Force, which manages critical shortages of PPE, ventilators,
and pharmaceutical materials by coordinating with industry
partners. Because H.R. 1166 would codify current practices, CBO
estimates that implementing those provisions would not affect
the federal budget.
The bill also would require the Administration to report
regularly to the Congress during public health emergencies,
detailing its use of authorities under the DPA. On the basis of
information about similar reports, CBO estimates that
satisfying that requirement would cost less than $500,000 over
the 2023-2028 period; any spending would be subject to the
availability of appropriated funds.
CBO has not reviewed H.R. 1166 for intergovernmental or
private-sector mandates. Section 4 of the Unfunded Mandates
Reform Act excludes from the application of that act any
legislative provisions that are necessary for national
security. CBO has determined that the provisions of the Defense
Production Act of 1950, as amended by the bill, would fall
under that exclusion.
The CBO staff contacts for this estimate are Caroline
Dorminey (for federal costs) and Brandon Lever (for mandates).
The estimate was reviewed by Chad Chirico, Deputy Director of
Budget Analysis.
Phillip L. Swagel,
Director, Congressional Budget Office.
NEW BUDGET AUTHORITY, ENTITLEMENT AUTHORITY,
AND TAX EXPENDITURES
Pursuant to clause 3(c)(2) of rule XIII of the Rules of the
House of Representatives, the Committee adopts as its own the
estimate of new budget authority, entitlement authority, or tax
expenditures or revenues contained in the cost estimate
prepared by the Director of the Congressional Budget Office
pursuant to section 402 of the Congressional Budget Act of
1973.
FEDERAL MANDATES STATEMENT
Pursuant to section 423 of the Unfunded Mandates Reform Act
of 1995, the Committee adopts as its own estimate the Federal
mandates as prepared by the Director of the Congressional
Budget Office.
ADVISORY COMMITTEE STATEMENT
No advisory committees within the meaning of section 5(b)
of the Federal Advisory Committee Act were created by this
legislation.
APPLICABILITY TO LEGISLATIVE BRANCH
The Committee finds that the legislation does not relate to
the terms and conditions of employment or access to public
services or accommodations within the meaning of section
102(b)(3) of the Congressional Accountability Act.
EARMARK IDENTIFICATION
Pursuant to clause 9 of rule XXI of the Rules of the House
of Representatives, the Committee has carefully reviewed the
provisions of the bill and states that the provisions of the
bill do not contain any congressional earmarks, limited tax
benefits, or limited tariff benefits within the meaning of the
rule.
DUPLICATION OF FEDERAL PROGRAMS
Pursuant to clause 3(c)(5) of rule XIII of the Rules of the
House of Representatives, the Committee states that no
provision of the bill establishes or reauthorizes a program of
the Federal Government known to be duplicative of another
Federal program, including any program that was included in a
report to Congress pursuant to section 21 of the Public Law
111-139 or the most recent Catalog of Federal Domestic
Assistance.
SECTION-BY-SECTION ANALYSIS OF THE LEGISLATION
Sec. 1: Short title
This Act may be cited as the ``Public Health Emergency
Medical Supplies Enhancement Act of 2023.''
Sec. 2: Public health emergencies
This section would amend the Defense Production Act (50
U.S.C. Sec. 4501-4568) to identify certain materials as scarce
and critical during an emergency period, as determined by
Secretary of the Health and Human Services or the Secretary of
Homeland Security. The bill also authorizes the prioritization
of materials for the federal government to exclude state,
local, or tribal purchases and creates an outreach
representative position to work with the private sector.
Sec. 3: Report on activities involving small business
This section directs the President to issue a report on the
authorities exercised and to provide briefings four months
after the submission of the report.
[all]